Krystal Biotech Inc banner

Krystal Biotech Inc
F:4KB

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
F:4KB
Watchlist
Price: 279.5 EUR -1.27% Market Closed
Market Cap: €8B

Wall St Price Targets

4KB Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast 4KB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4KB is 174.29 EUR with a low forecast of 101.79 EUR and a high forecast of 233.3 EUR.

Lowest Forecast
Price Target
101.79 EUR
64% Downside
Average Forecast
Price Target
174.29 EUR
38% Downside
Highest Forecast
Price Target
233.3 EUR
17% Downside
Krystal Biotech Inc Competitors:
Price Targets
IBEX
Ibex Ltd
8% Upside
ONDS
Ondas Holdings Inc
125% Upside

Revenue
Forecast

N/A
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 22%.

Gross Profit
Forecast

N/A
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Gross Profit over the next 8 years is 22%.

Operating Income
Forecast

N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Operating Income over the next 8 years is 31%.

Pre-Tax Income
Forecast

N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.

Net Income
Forecast

N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

The compound annual growth rate for Net Income over the next 8 years is 21%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4KB's stock price target?
Price Target
174.29 EUR

According to Wall Street analysts, the average 1-year price target for 4KB is 174.29 EUR with a low forecast of 101.79 EUR and a high forecast of 233.3 EUR.

What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%

The compound annual growth rate for Revenue over the next 8 years is 22%.

What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%

The compound annual growth rate for Gross Profit over the next 8 years is 22%.

What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%

The compound annual growth rate for Operating Income over the next 8 years is 31%.

What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.

What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%

The compound annual growth rate for Net Income over the next 8 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett